|
2023 Conference Publication Suppression of KRAS and CBL Mutations and Hematological Improvement By Lenzilumab and Azacitidine Treatment in Proliferative Chronic Myelomonocytic LeukemiaKamel, Maha M., Kutyna, Monika, Ross, David M., Lane, Steven W., Thompson-Peach, Chloe, Fong, Chun Yew, Yong, Agnes S. M., Yeung, David T., Hughes, Timothy P., Hiwase, Devendra and Thomas, Daniel (2023). Suppression of KRAS and CBL Mutations and Hematological Improvement By Lenzilumab and Azacitidine Treatment in Proliferative Chronic Myelomonocytic Leukemia. 65th ASH Annual Meeting, San Diego, CA United States, 9-12 December 2023. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2023-188340 |
|
2023 Conference Publication Lenzilumab in Addition to Azacitidine Improves Complete Response Rates in Chronic Myelomonocytic LeukemiaHiwase, Devendra, Ross, David M., Lane, Steven W., Thompson-Peach, Chloe, Fong, Chun Yew, Yong, Agnes S. M., Yeung, David T., Hughes, Timothy P. and Thomas, Daniel (2023). Lenzilumab in Addition to Azacitidine Improves Complete Response Rates in Chronic Myelomonocytic Leukemia. 65th ASH Annual Meeting, San Diego, CA United States, 9-12 December 2023. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2023-179688 |
|
2023 Conference Publication Trp53-Loss in Hematopoietic Stem Cells Drives the Evolutionary Process of Leukemic Transformation in a Jak2 V617F-Driven Myeloproliferative Neoplasms Mouse ModelZhang, Ranran, Janardhanan, Yashaswini, Haldar, Rohit, Cooper, Leanne, Jaquelin, Sebastien, Straube, Jasmin, Bywater, Megan and Lane, Steven W. (2023). Trp53-Loss in Hematopoietic Stem Cells Drives the Evolutionary Process of Leukemic Transformation in a Jak2 V617F-Driven Myeloproliferative Neoplasms Mouse Model. 65th ASH Annual Meeting, San Diego, CA United States, 9-12 December 2023. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2023-188150 |
|
2023 Conference Publication Prospective MRI and neurocognitive assessment of “Chemobrain” in acute myeloid leukaemia: the mineral studyScott, Ashleigh, Lo, Ada, Thompson, Kate, Xia, Ying, Bodimeade, Harriet, Fazlollahi, Amir, Curley, Cameron, Lane, Steven W., Morris, Kirk Lachlan, McNamara, Caroline Jane, Pillai, Elango S., Weber, Nicholas, Salvado, Olivier, McMahon, Katie L. and Kennedy, Glen A. (2023). Prospective MRI and neurocognitive assessment of “Chemobrain” in acute myeloid leukaemia: the mineral study. 65th American Society of Hematology (ASH) Annual Meeting and Exposition, San Diego, CA, United States, 9-12 December 2023. Washington, DC, United States: American Society of Hematology. doi: 10.1182/blood-2023-190301 |
|
2023 Conference Publication Cytokine and Mutation Profiling Reveal Patterns of Complete Remission Rates with Lenzilumab Combination Therapy in Chronic Myelomonocytic LeukemiaKutyna, Monika, Kamel, Maha M., Ross, David M., Yong, Agnes S. M., Fong, Chun Yew, Thompson-Peach, Chloe, Lane, Steven W., Yeung, David T., Hughes, Timothy P., Hiwase, Devendra and Thomas, Daniel (2023). Cytokine and Mutation Profiling Reveal Patterns of Complete Remission Rates with Lenzilumab Combination Therapy in Chronic Myelomonocytic Leukemia. 65th ASH Annual Meeting, San Diego, CA United States, 9-12 December 2023. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2023-179706 |
|
2023 Conference Publication Early Generation Telomerase Deficient Mice to Investigate Clonal Hematopoiesis in AgingBruedigam, Claudia, Porter, Amy H., Straube, Jasmin, Cheng, Guidan, Heidel, Florian H. and Lane, Steven W. (2023). Early Generation Telomerase Deficient Mice to Investigate Clonal Hematopoiesis in Aging. 65th ASH Annual Meeting, San Diego, CA United States, 9-12 December 2023. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2023-191246 |
|
2023 Journal Article Clearing the way for new therapies in clonal hematopoiesisLing, Victoria Y. and Lane, Steven W. (2023). Clearing the way for new therapies in clonal hematopoiesis. Blood Advances, 7 (22), 7151-7152. doi: 10.1182/bloodadvances.2023011728 |
|
2023 Conference Publication Excellent Early and Major Molecular Responses Observed with Asciminib Treatment for CP-CML: Results from the ALLG CML13 Ascend-CML StudyYeung, David T., Shanmuganathan, Naranie, Reynolds, John, Branford, Susan, Walia, Mannu, Yong, Agnes S. M., Shortt, Jake, Burbury, Kate, Chee, Lynette C.Y., Viiala, Nick, Cunningham, Ilona, Ross, David M., D'Souza, Alwyn Bernard, Wright, Matthew P.F., Harrup, Rosemary Anne, Forsyth, Cecily, Filshie, Robin, Browett, Peter J., Lane, Steven W., Grove, Carolyn, Grigg, Andrew P., Hughes, Timothy P. and on Behalf Of The ALLG (2023). Excellent Early and Major Molecular Responses Observed with Asciminib Treatment for CP-CML: Results from the ALLG CML13 Ascend-CML Study. 65th ASH Annual Meeting, San Diego, CA United States, 9-12 December 2023. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2023-172583 |
|
2023 Journal Article Demographic, clinical and laboratory differences between paediatric acute COVID-19 and PIMS-TS-results from a single centre study in the UKJiju, Prince, Matalliotakis, Michail, Lane, Steven, Wong, Waison, Hedrich, Christian M. and Pain, Clare E. (2023). Demographic, clinical and laboratory differences between paediatric acute COVID-19 and PIMS-TS-results from a single centre study in the UK. Frontiers in Pediatrics, 11 1219654, 1-11. doi: 10.3389/fped.2023.1219654 |
|
2023 Journal Article Genome-wide transcription factor binding maps reveal cell-specific changes in the regulatory architecture of human HSPCSubramanian, Shruthi, Thoms, Julie A I, Huang, Yizhou, Cornejo Paramo, Carina Paola, Koch, Forrest Charles, Jacquelin, Sebastien, Shen, Sylvie, Song, Emma, Joshi, Swapna, Brownlee, Christopher Peter, Woll, Petter S., Chacon-Fajardo, Diego, Beck, Dominik, Curtis, David J, Yehson, Kenneth, Antonenas, Vicki, O'Brien, Tracey, Trickett, Annette, Powell, Jason A., Lewis, Ian D, Pitson, Stuart M, Gandhi, Maher K., Lane, Steven W, Vafaee, Fatemeh, Wong, Emily, Gottgens, Berthold, Rokny, Hamid, Wong, Jason Wing Hon and Pimanda, John E (2023). Genome-wide transcription factor binding maps reveal cell-specific changes in the regulatory architecture of human HSPC. Blood Journal, 142 (17), 1448-1462. doi: 10.1182/blood.2023021120 |
|
2023 Journal Article Evaluation of a novel, multicomponent anxiety management programme for people with intellectual disability: protocol for a mixed-methods, quasi-experimental feasibility studyActon, Daniel, Williams, Jonathan, Woodrow, Ceri, Talbot, Grace, Jones, Steven, Lane, Steven and Jaydeokar, Sujeet (2023). Evaluation of a novel, multicomponent anxiety management programme for people with intellectual disability: protocol for a mixed-methods, quasi-experimental feasibility study. BMJ Open, 13 (9) e078411, 9. doi: 10.1136/bmjopen-2023-078411 |
|
2023 Journal Article The use of breast milk iodine concentration in the first week of lactation as a biomarker of iodine status in breast-feeding womenLiu, Shuchang, Sharp, Andrew, Luo, Xiaoqin, Lane, Steven, Villanueva, Elmer V., Lu, Zhiliang and Ma, Zheng Feei (2023). The use of breast milk iodine concentration in the first week of lactation as a biomarker of iodine status in breast-feeding women. British Journal of Nutrition, 131 (2), 286-295. doi: 10.1017/S0007114523001897 |
|
2023 Journal Article ACTivity as medicine In Oncology for Head and Neck (ACTIOHN): protocol for a feasibility study investigating a patient-centred approach to exercise for people with head and neck cancerMidgley, Adrian W., Levy, Andrew R., Rogers, Simon N., Brooker, Rachel C., Bryant, Valerie, Cherry, Mary Gemma, Lane, Steven, Nugent, Michael M., Price, Ruth, Schache, Andrew G., Young, Bridget and Patterson, Joanne M. (2023). ACTivity as medicine In Oncology for Head and Neck (ACTIOHN): protocol for a feasibility study investigating a patient-centred approach to exercise for people with head and neck cancer. PLoS One, 18 (8) e0289911, 1-20. doi: 10.1371/journal.pone.0289911 |
|
2023 Journal Article Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemiaEifert, Theresa, Hsu, Chen-Jen, Becker, Alicia L., Graessle, Sarah, Horne, Arik, Bemmann, Franziska, Zhang, Qirui, Heuser, Michael, Vasioukhin, Valeri, Scholl, Sebastian, Hochhaus, Andreas, Siegerist, Florian, Endlich, Nicole, Bullinger, Lars, Lane, Steven W., Haas, Simon, Schnoeder, Tina M. and Heidel, Florian H. (2023). Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemia. Leukemia, 37 (10), 2027-2035. doi: 10.1038/s41375-023-02005-9 |
|
2023 Journal Article The TRIM31-paradox: an unexpected benefit for leukemia stem cellsStraube, Jasmin and Lane, Steven W. (2023). The TRIM31-paradox: an unexpected benefit for leukemia stem cells. Haematologica, 108 (8), 1982-1983. doi: 10.3324/haematol.2022.282622 |
|
2023 Journal Article Follow up of women after obstetric anal sphincter injuries (OASI)-what is the role of anorectal testing?Badri, Hawra, Fowler, Gillian and Lane, Steven (2023). Follow up of women after obstetric anal sphincter injuries (OASI)-what is the role of anorectal testing?. Neurourology and Urodynamics, 42 (6), 1374-1380. doi: 10.1002/nau.25220 |
|
2023 Journal Article Using technology to reduce critical deterioration (the DETECT study): a cost analysis of care costs at a tertiary children's hospital in the United KingdomCosta, Eduardo, Mateus, Ceu, Carter, Bernie, Saron, Holly, Eyton-Chong, Chin-Kien, Mehta, Fulya, Lane, Steven, Siner, Sarah, Dean, Jason, Barnes, Michael, McNally, Chris, Lambert, Caroline, Hollingsworth, Bruce, Carrol, Enitan D. D. and Sefton, Gerri (2023). Using technology to reduce critical deterioration (the DETECT study): a cost analysis of care costs at a tertiary children's hospital in the United Kingdom. BMC Health Services Research, 23 (1) 725, 1-10. doi: 10.1186/s12913-023-09739-3 |
|
2023 Journal Article Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentationIland, Harry J, Russell, Nigel H., Dillon, Richard, Schuh, Andre C., Tedjaseputra, Aditya, Wei, Andrew H., Khwaja, Asim, Knapper, Steven, Lane, Steven W, Reynolds, John, McMullin, Mary Frances Frances, Martin, Annalise Maria, Tan, Peter, Taussig, David Christopher C, Wong, Anny, Taper, John M, Fraga, Christina, Kelly, Richard, Tawana, Kiran, Mehta, Priyanka, Mina, Alain, Altman, Jessica K., Mølle, Ingolf, Tauro, Sudhir and Tholouli, Eleni (2023). Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation. Blood Advances, 7 (11), 2580-2585. doi: 10.1182/bloodadvances.2022007126 |
|
2023 Journal Article Shelter from the cytokine storm in myelofibrosisLane, Steven W. (2023). Shelter from the cytokine storm in myelofibrosis. Blood, 141 (20), 2415-2416. doi: 10.1182/blood.2023019779 |
|
2023 Journal Article Could an artificial intelligence approach to prior authorization be more human?Lenert, Leslie A., Lane, Steven and Wehbe, Ramsey (2023). Could an artificial intelligence approach to prior authorization be more human?. Journal of the American Medical Informatics Association, 30 (5), 989-994. doi: 10.1093/jamia/ocad016 |
